CV Sciences, Inc. (CVSI)
| Market Cap | 5.64M |
| Revenue (ttm) | 15.71M |
| Net Income (ttm) | -2.39M |
| Shares Out | 184.26M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,000 |
| Average Volume | 190,525 |
| Open | 0.0316 |
| Previous Close | 0.0306 |
| Day's Range | 0.0316 - 0.0316 |
| 52-Week Range | 0.0300 - 0.1000 |
| Beta | 0.63 |
| RSI | 47.57 |
| Earnings Date | Mar 28, 2025 |
About CV Sciences
CV Sciences, Inc. develops, manufactures, markets, and sells herbal supplements and hemp-based cannabidiol (CBD) in North America. The company offers its products under the PlusCBD, ProCBD, HappyLane, and PlusCBD Pet brands in the health care market sector, including nutraceutical, beauty care, specialty foods, and pet products through its websites, select distributors, brick and mortar retailers, and select e-tailers. It is also developing cannabinoids intended to treat medical indications, including CVSI-007 that combines CBD and nicotine for... [Read more]
Full Company ProfileFinancial Performance
Financial StatementsNews
CV Sciences, Inc. (CVSI) Q4 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q4 2024 Earnings Conference Call March 27, 2025 10:00 AM ET Company Participants Brendan Hawkins - Investor Relations Joseph Dowling - Chief Executive Officer Joerg Gras...
CV Sciences, Inc. Reports Fiscal Year-End 2024 Financial Results
SAN DIEGO, CA / ACCESS Newswire / March 27, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extra...
CV Sciences Unveils Lunar Fox Food Co., an All-New Line of Plant-Based Foods
The innovative product line offers a unique choice of plant-based, 100% natural alternatives to the foods everyone loves. SAN DIEGO, CA / ACCESS Newswire / March 26, 2025 / CV Sciences, Inc. (OTCQB:CV...
Cannabis Stock Gainers And Losers From March 21, 2025
GAINERS: 1933 Industries (OTC: TGIFF) shares closed up 38.43% at $0.01 CordovaCann (OTC: LVRLF) shares closed up 33.11% at $0.08 CV Sciences (OTC: CVSI) shares closed up 10.24% at $0.03 Leafbuyer T...
CV Sciences, Inc. To Announce Year End and Fourth Quarter 2024 Results On March 27, 2025
SAN DIEGO, CALIFORNIA / ACCESS Newswire / March 20, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in he...
Marijuana Stock Movers For March 14, 2025
GAINERS: Global Hemp Group (OTC: GBHPF) shares closed up 250.00% at $0.04 1933 Industries (OTC: TGIFF) shares closed up 91.18% at $0.00 Zoned Properties (OTC: ZDPY) shares closed up 61.78% at $0.37...
CV Sciences Unveils New Aura Collection THC Fizz Tablets
The innovative, lemon-flavored fast-acting tablets provide a quick, uplifting experience, perfect for enhancing social moments or relaxing at home. SAN DIEGO, CA / ACCESS Newswire / February 5, 2025 /...
CV Sciences enters into agreement to acquire Extract Labs
CV Sciences, Inc. Enters Into Definitive Agreement to Acquire Extract Labs
SAN DIEGO , Nov. 21, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences Q3: Revenue Stable Amid New Launches, Financing
CV Sciences, Inc. (OTCQB: CVSI), a hemp -focused wellness company, announced stable revenue in its Q3 2024 financials on Thursday. The company generated $3.9 million in revenue, a slight decline from...
CV Sciences, Inc. (CVSI) Q3 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q3 2024 Earnings Conference Call November 14, 2024 10:00 AM ETCompany ParticipantsBrendan Hawkins - Investor RelationsJoseph...
CV Sciences Non-GAAP EPS of $0.00, revenue of $3.87M
CV Sciences, Inc. Reports Third Quarter 2024 Financial Results
SAN DIEGO , Nov. 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. To Announce Third Quarter 2024 Results On November 14, 2024
SAN DIEGO , Nov. 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
Marijuana Stock Movers For October 23, 2024
GAINERS: Leafbuyer Techs (OTC: LBUY) shares closed up 100.00% at $0.00 4Front Ventures (OTC: FFNTF) shares closed up 24.89% at $0.06 Pharmadrug (OTC: LMLLF) shares closed up 15.85% at $0.02 Body an...
Cannabis Stock Gainers And Losers From October 4, 2024
GAINERS: CLS Holdings USA (OTC: CLSH) shares closed up 23.72% at $0.05 CordovaCann (OTC: LVRLF) shares closed up 16.96% at $0.07 4Front Ventures (OTC: FFNTF) shares closed up 10.82% at $0.05 CV Sci...
CV Sciences Launches +PlusHLTH, a New Line of Cannabinoid-Free Supplements
Designed to elevate focus, mood, energy, and metabolism with clinically proven wellness ingredients Available in three variations - Clarity, Peace, and ReShape SAN DIEGO , Aug. 27, 2024 /PRNewswire/ -...
Bearish Sentiment Across The Cannabis Space - Check Full Movers For August 26, 2024
GAINERS: Target Group (OTC: CBDY) shares closed up 33.33% at $0.00 CNBX Pharmaceuticals (OTC: CNBX) shares closed up 28.57% at $0.01 Nextleaf Solutions (OTC: OILFF) shares closed up 19.05% at $0.07...
CV Sciences, Inc. (CVSI) Q2 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q2 2024 Earnings Conference Call August 13, 2024 10:00 AM ETCompany ParticipantsBrendan Hawkins - Investor RelationsJoseph...
CV Sciences, Inc. Reports Second Quarter 2024 Financial Results
SAN DIEGO , Aug. 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. To Announce Second Quarter 2024 Results On August 13, 2024
SAN DIEGO , Aug. 7, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. (CVSI) Q1 2024 Earnings Call Transcript
CV Sciences, Inc. (OTCQB:CVSI) Q1 2024 Earnings Conference Call May 14, 2024 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants...
CV Sciences, Inc. Reports First Quarter 2024 Financial Results
SAN DIEGO , May 14, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB: CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV SCIENCES, INC. ACQUIRES ELEVATED SOFTGELS, A FLEXIBLE, LOW-MOQ, NUTRACEUTICAL MANUFACTURER
SAN DIEGO , May 13, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and o...
CV Sciences, Inc. To Announce First Quarter 2024 Results On May 14, 2024
SAN DIEGO , May 8, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and ot...